SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-069912
Filing Date
2023-06-09
Accepted
2023-06-09 16:12:06
Documents
1
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2318251-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2318251-8_4seq1.xml 4 4372
  Complete submission text file 0001104659-23-069912.txt   5875
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PERRYVILLE III CORPORATE PARK 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address
Fernandes Peter (Reporting) CIK: 0001642618 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 231005384